This content requires a premium subscription.
Please
log in
or
subscribe
to continue.
JACC Specialty Journals
JACC: Basic to Translational Science - The Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV-2 Infection
Released: Jan 25, 2021
Commentary by Dr. Douglas Mann
JACC: Basic to Translational Science - The Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV-2 Infection
00:00:00
